Clinical trial
Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung "Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II"
NCT05987189 is registered in ClinicalTrials.gov with Hummingbird Diagnostics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic Performance of Small RNA Blood Test in Patients Undergoing Follow-up Imaging After Positive Low Dose CT Screening for Cancer of the Lung "Early Detection of Lung Cancer Based on Small RNA Signatures - Boston II"
- Lead sponsor
- Hummingbird Diagnostics
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- October 18, 2023
- Completion date
- July 31, 2027
- Enrollment
- 2,000 (estimated)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
lung cancer